Cargando…
Gemigliptin: Newer Promising Gliptin for Type 2 Diabetes Mellitus
The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, and studies have revealed certain advantages of gem...
Autores principales: | Gutch, Manish, Joshi, Abhay, Kumar, Sukriti, Agarwal, Avinash, Pahan, Rajendra Kumar, Razi, Syed Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729681/ https://www.ncbi.nlm.nih.gov/pubmed/29285456 http://dx.doi.org/10.4103/ijem.IJEM_20_17 |
Ejemplares similares
-
Diabetes mellitus: Trends in northern India
por: Gutch, Manish, et al.
Publicado: (2014) -
Thyroid functions and serum lipid profile in metabolic syndrome
por: Gutch, Manish, et al.
Publicado: (2017) -
Isoniazid induced childhood diabetes: A rare phenomenon
por: Manish, Gutch, et al.
Publicado: (2015) -
Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
por: Muthukrishnan, J., et al.
Publicado: (2012) -
Pituitary stalk interruption syndrome: Case report of three cases with review of literature
por: Gutch, Manish, et al.
Publicado: (2014)